535
Views
13
CrossRef citations to date
0
Altmetric
ADENOMYOSIS

Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest

, , &
Pages 521-524 | Received 06 Apr 2019, Accepted 06 Aug 2019, Published online: 29 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Keitaro Yamanaka, Keiichi Washio, Akiko Uchida, Yuki Sasagawa, Masashi Nishimoto, Yui Yamasaki, Satoshi Nagamata & Yoshito Terai. (2023) Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix. Gynecological Endocrinology 39:1.
Read now
Juan Miao, Jing Lu, Juanjuan Tang & Pinhong Lu. (2022) Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice. Gynecological Endocrinology 38:8, pages 656-660.
Read now

Articles from other publishers (11)

Becky MacGregor, Malcolm G. Munro & Mary Ann Lumsden. (2023) Therapeutic options for the management of abnormal uterine bleeding. International Journal of Gynecology & Obstetrics 162:S2, pages 43-57.
Crossref
Vitaly B. Tskhay, Anna A. Bakunina & Gulnar T. Mikailli. (2023) Medical treatment of adenomyosis: a literature review. Gynecology 25:2, pages 133-139.
Crossref
Fani Gkrozou, Anastasia Vatopoulou, Chara Skentou & Minas Paschopoulos. (2023) Diagnosis and Treatment of Adenomyosis with Office Hysteroscopy—A Narrative Review of Literature. Diagnostics 13:13, pages 2182.
Crossref
E. Shirin Dason, Madalina Maxim, Ari Sanders, Jessica Papillon-Smith, Danny Ng, Crystal Chan & Mara Sobel. (2023) Directive clinique no 437 : Diagnostic et prise en charge de l’adénomyose. Journal of Obstetrics and Gynaecology Canada 45:6, pages 430-444.e1.
Crossref
E. Shirin Dason, Madalina Maxim, Ari Sanders, Jessica Papillon-Smith, Danny Ng, Crystal Chan & Mara Sobel. (2023) Guideline No. 437: Diagnosis and Management of Adenomyosis. Journal of Obstetrics and Gynaecology Canada 45:6, pages 417-429.e1.
Crossref
Xiaotong Han, Xinran Gao, Feng Wang, Chunliang Shang, Zhongyu Liu & Hongyan Guo. (2023) Heterogeneity of clinical symptoms and therapeutic strategies for different subtypes of adenomyosis: An initial single‐center study in China. International Journal of Gynecology & Obstetrics 161:3, pages 775-783.
Crossref
I‐San Chan, Teh‐Fu Hsu, Ying‐Chu Shih, Yen‐Hou Chang, Peng‐Hui Wang & Yi‐Jen Chen. (2023) Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study. International Journal of Gynecology & Obstetrics 161:3, pages 751-759.
Crossref
Yiyue Fan, Shaomi Zhu & Xin Liang. (2022) Conservative surgical and drug therapies for adenomyosis Medicine. Reproductive Biology 22:3, pages 100664.
Crossref
Bahi Elbasueny, Maya Geerts, Catherine Allaire, Paul J. Yong & Mohamed A. Bedaiwy. (2022) Medical Treatment of Adenomyosis. Current Obstetrics and Gynecology Reports 11:2, pages 103-117.
Crossref
Jacques Donnez, Christina Anna Stratopoulou & Marie-Madeleine Dolmans. (2021) Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists. International Journal of Environmental Research and Public Health 18:19, pages 9941.
Crossref
Ahmed I. Hassanin, Ahmed A. Youssef, Asmaa M. Yousef & Mohammed K. Ali. (2021) Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial. International Journal of Gynecology & Obstetrics 154:2, pages 263-269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.